Renal problems after lung transplantation of cystic fibrosis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 7, 2001, Pages 1324-1328

  Schindler, Ralf ^a   Radke, Cornelia ^a   Paul, Karl ^a   Frei, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cystic fibrosis; Diabetes mellitus; Lung transplantation; Nephrotoxicity; Renal failure

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOKINE ANTIBODY; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLONE DERIVATIVE; RAPAMYCIN; SEVELAMER;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CALORIC INTAKE; CASE REPORT; CYSTIC FIBROSIS; DEHYDRATION; DIABETES MELLITUS; DRUG TOXICITY; GLOMERULUS FILTRATION RATE; HUMAN; HYPEROXALURIA; HYPERTENSION; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LIFE EXPECTANCY; LUNG TRANSPLANTATION; MALE; NEPHROLOGY; NEPHROTOXICITY; OTOTOXICITY; OUTCOMES RESEARCH; PATIENT MONITORING; PHYSIOTHERAPY; PRIORITY JOURNAL; UROLITHIASIS;

EID: 0034945613     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.7.1324     Document Type: Article

References (24)

1. Management of pulmonary disease in patients with cystic fibrosis
2. Long-term renal outcome after lung transplantation is predicted by the 1-month postoperative renal function loss
3. Voluntary dehydration and heat intolerance in cystic fibrosis
4. Microscopic nephrocalcinosis in cystic fibrosis
5. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
6. Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside
7. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
8. Kidney function in cyclosporine-treated paediatric pulmonary transplant recipients
9. Cyclosporin nephrotoxicity following cardiac transplantation
10. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients
11. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing
12. Overview of the clinical experience with Neoral in transplantation
13. Transient renal failure due to simultaneous ibuprofen and aminoglycoside therapy in children with cystic fibrosis
14. Bone mineral status in prepubertal children with cystic fibrosis
15. Urinary excretion substances in patients with cystic fibrosis: Risk of urolithiasis
16. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria
17. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure
18. The clinical significance of assessment of serum oxalate saturation in the hyperoxaluria syndromes
19. Evidence that calgranulin is produced by kidney cells and is an inhibitor of calcium oxalate crystallization
20. Nephropathy in patients with type 2 diabetes mellitus
21. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine
22. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
23. Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients